Annual Drug Patent Expirations for YOSPRALA Yosprala is a drug marketed by Genus Lifesciences and is included in one NDA. […]
New patent expiration for Genus Lifesciences drug YOSPRALA Read Post »
Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one
New patent expiration for Novo Nordisk drug VICTOZA Read Post »
LEQVIO (inclisiran sodium) Novartis Patent: 8,232,383 Expiration: Feb 20, 2023 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of February 19, 2023 Read Post »
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It
Annual Drug Patent Expirations for TEMODAR Temodar is a drug marketed by Merck Sharp Dohme and is included in two
New patent expiration for Merck Sharp drug TEMODAR Read Post »
Annual Drug Patent Expirations for ZECUITY Zecuity is a drug marketed by Teva Branded Pharm and is included in one
New patent expiration for Teva Branded drug ZECUITY Read Post »
Annual Drug Patent Expirations for TRICOR Tricor is a drug marketed by Abbvie and Abbvie Inc and is included in
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It
Annual Drug Patent Expirations for DALIRESP Daliresp is a drug marketed by Astrazeneca and is included in one NDA. It
New patent expiration for Astrazeneca drug DALIRESP Read Post »
Get fresh news and insights, drug patent expirations & more…
